Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo

British Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 421-429

  Bradshaw, T D ^a   Shi, D F ^a   Schultz, R J ^b   Paull, K D ^b   Kelland, L ^c   Wilson, A ^d   Garner, C ^d   Fiebig, H H ^e   Wrigley, S ^a   Stevens, M F G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d DERBY CITY GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

2 (4 aminophenyl)benzothiazole; 5 (4 dimethylaminophenylazo)quinoline; COMPARE analysis; Ovarian carcinoma

Indexed keywords

BENZOTHIAZOLE DERIVATIVE; POLYVINYLIDENE FLUORIDE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL GROWTH; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 7344246555     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.510     Document Type: Article

References (13)

1. Abu Sinna G, Beackman G, Lundgren E and Roos G (1979) Characterisation of two new ovarian carcinoma cell lines. Gynecol Oncol 7: 267-280
2. Akama T, Ishida H, Shida Y, Kimura U, Gomi K, Saito H, Fuse E, Kobayashi N, Yoda N and Kasai M (1997) Design and synthesis of potent 5,4′-diaminoflavone derivatives based on metabolic considerations. J Med Chem 40: 1894-1900
3. Boyd MR (1989) Status of the NCI preclinical antitumor drug discovery screen. In Cancer: Principles and Practice of Oncology Updates, Vol. 3, DeVita VT. Hellman S and Rosenberg SA. (eds). JP Lippincott: Philadelphia, pp. 1-12
4. Bradshaw TD, Wrigley S, Shi D-F, Schultz RJ, Paull KD and Stevens MFG (1998) 2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity. Br J Cancer 77: 745-752
5. Hamburger AW and Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197: 461-463
6. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolfe A, Gray-Goodrich M, Campbell H and Boyd MR (1991) Feasibility of a high-flux anticancer drug utilizing a diverse panel of human tumour cell lines in culture. J Natl Cancer Inst 83: 757-766
7. Monks A, Scudiero DA, Johnson GJ, Paull KD and Sausville EA (1997) NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Anti-Cancer Drug Design 12: 533-541
8. Shi D-F, Bradshaw TD, Wrigley S, McCall CJ, Lelieveld P, Fichtner I and Stevens MFG (1996) Antitumour bezothiazoles. 3. Synthesis of 244-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chen 39: 3375-3384
9. Stevens MFG, McCall CJ, Lelievold P, Alexander P, Richter A and Davies DE (1994) Structural studies on bioactive compounds. 23, Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin, J Med Chem 37: 1689-1695
10. Stevens MFG, McCall CJ and Lelieveld P (1995) Bonzazole compounds for use in therapy. International Application Number WO 95/06469: Stevens MFG, Shi D-F, Bradshaw TD and Wrigley S, Bonzazolc compound. Br Patent, 9503946.7
11. Weinstein JR, Myers TG, O'Connor PM, Friend SH, Fomace AJF. Kohn KW, Fojo T, Bates SE, Rubinstein I.V, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE and Paull KD (1997) An information-intensive approach to the molecular phamacology of cancer. Science 275: 343-349
12. Wilson AP (1984) Characterisation of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary, J Natl Cancer Inst 72: 513-521
13. Yates PC, McCall CJ and Stevens MFG (1991) Strucutural studies on benzothiazoles. Crystal and molecular structure of 5,6-dimethoxy-2-(4-methoxyphenyl)-benzothiazole and molecular orbital calculations on related compounds. Tetrahedron 47: 6493-6502